A Dermatology Times interview supports reviewing skin-care goals after acne control, with AAD context on menopause, dryness and sun protection.
On October 9, 2026, Dermatology Times published “Beyond Acne: How Personalized Skin Care Evolves With Patients Over Time” by dermatologist Whitney Tolpinrud and Shannon Heaning. The report examines how skin-care goals may shift after acne is controlled.
A routine built around active acne has an immediate purpose: controlling acne. In the Dermatology Times report, Tolpinrud describes what can happen when that purpose has been met. Some people may want to address pigmentation left after acne. Others may be more interested in prevention or maintaining skin health over time.
The framing being questioned is a fixed endpoint, not a formally revised medical standard. Acne control need not mean that every ingredient stays forever or that all care stops. For a midlife reader, the useful shift is from preserving an old routine to asking whether its purpose still matches her concerns.
The report is a practitioner interview, not a clinical trial. It provides no patient counts or comparative outcome data and supplies no universal regimen or standard concentration-adjustment schedule. It does not establish that every midlife woman benefits from tretinoin. The reported interest in prevention is not a survey-based estimate.
Tolpinrud is identified as Curology’s chief dermatologist. The article describes Curology as traditionally focused on acne and other common skin concerns, while its sister brand Agency focuses on aging concerns and skin longevity. Those descriptions are commercial positioning rather than evidence of better outcomes.
Neither the report nor the American Academy of Dermatology’s menopause guidance makes every skin change hormonal or establishes that a cosmetic prescription will reverse it. Read the report as a reason for a clearer clinical discussion, not as proof of a new long-term treatment package.
For women thinking about skin and hair changes in midlife, the American Academy of Dermatology offers a useful companion to the interview. The AAD says menopause-related hormonal changes can leave skin dry, slack or thin. Its guidance keeps everyday protection and comfort in the conversation rather than making prescription treatment the starting point.
The AAD’s recommendations include:
These priorities give the idea of long-term skin health a more concrete meaning. In this context, care includes protection and managing dryness. It does not have to be organized entirely around changing visible signs of age.
A woman can care about pigmentation or appearance while also wanting a routine that feels comfortable and manageable. Those are legitimate goals to bring to a consultation. The interview’s emphasis on changing priorities makes room for that conversation without requiring every concern to become a new prescription target.
For readers navigating the hormonal transition, the distinction is useful: menopause provides context for a discussion, not an automatic explanation for everything noticed in the mirror.
The practical value of this report lies in making a review more specific. Rather than asking only whether to keep using the same products, a conversation can separate the original concern from the current one. That keeps the discussion focused on purpose and experience rather than the size of the routine.
Useful questions drawn from the report’s patient-centered approach include:
These are discussion prompts for a dermatologist, not instructions to stop or change a prescription. Their purpose is to make the reasoning behind the plan understandable. A woman should be able to describe what she hopes care will address and hear why a particular ingredient remains relevant.
The distinction between a new concern and a new purchase also matters. If the priority is now dryness rather than active acne, that deserves to be stated clearly during a review. If pigmentation remains the main concern, that deserves a focused discussion too. The report supports revisiting the goal before assuming what the next product should be.
Speaking about well-controlled acne, Tolpinrud told Dermatology Times: “it doesn't mean that skincare should stop.”
Elsewhere in the interview, she describes care as a continuum in which ingredients and percentages can change. The useful idea is not loyalty to a formula. It is continued attention to what the person now wants care to address.
In practice, this report points toward reviewing goals and tolerability over time rather than treating acne control as a cue for either unchanged prescriptions or an automatic next product.
Reviewing an acne prescription belongs with the woman using it and her dermatologist; Refemina adds an editorial perspective on the changing goals behind that discussion. Its focus is to separate research from product-led claims so a concern about appearance is not automatically recast as a need for hormones, supplements or weight loss.
Follow Refemina for research-led insights on menopause, strength, metabolism, nutrition, skin, intimacy and confidence through midlife. New articles turn complex topics into clear, useful context.
Keep learning about the changes that shape energy, strength, confidence and wellbeing through midlife.
Explore Resources